Submissions

All the required supporting documents will be submitted together with the manuscript. Authors are required to upload a scanned original of the completed cover letter in PDF format. The cover letter should be signed by all the authors. In a cover letter the authors should confirm that:

• all participants who have made a significant contribution to the study are presented as co-authors;
• those who did not participate in the study should not be listed as co-authors;
• all co-authors have seen and approved the final version of the document and agreed to submit it for publication.

When submitting the manuscript to the journal, please consider the Uniform Requirements for Manuscripts Submitted to Biomedical Journals developed by the International Committee of Medical Journal Editors.

Editorial team selects manuscripts to be published in according with the Journal’s publication ethics statement (see in details here). The journal publishes the results of research conducted in compliance with the principles of biomedical ethics and that meet Good Clinical Practice (GCP) standards. The journal only accepts original manuscripts that have not previously been published (including publications in any other language) or submitted for publication in any other journal.

In case of ethics violation detection a manuscript will be rejected despite of publication stage.

The title page should include:

• article’s title;
• authors’ names (first and middle name initials, full surname);
• place of work of each author (official name of the institution);
• the author responsible for correspondence with the editorial team should be tagged with an asterisk (*), and provide their e-mail and telephone contact details (for the use of the editorial team; these will not be published).

The final page should include information about the authors in the order of their presentation in the article:

• full name (first, middle name (if applicable), surname);
• position held; official name of institution, and name of department/division;
• degree(s);
• authors’ academic indices:
• ORCID (obligatory for all authors);
• ResearcherID, ScopusID (if applicable);
• e-mail addresses. The author responsible for correspondence with the editorial team should be tagged with an asterisk (*).

Manuscripts are accepted in DOC, DOCX, and RTF format. Text should be in the Times New Roman font, in 14-point font, with a one-and-a-half line spacing. All pages should be numbered.

Italic and bold typefaces are allowed for emphasis within the text; underlining is only applicable for Internet links.

Manuscript length (excl. abstract, illustrative materials, and bibliography):

• research results should not exceed 40,000 characters, including spaces;
• reviews should not exceed 60,000 characters, including spaces;
• case reports should not exceed 20,000 characters, including spaces;
• information, commentary, and letters to the editor should not exceed 10,000 characters, including spaces.

Longer manuscripts are only accepted with the specific agreement of the editors.

Recommended guidelines for manuscript structure

We recommend that authors follow the international guidelines for transparent and accurate reporting data in scholarly articles collected on the EQUATOR Network platform. Reporting guidelines for the main study types are:

• Observational studies (STROBE& Extensions)
• Randomized trials (CONSORT& Extensions)
• Study protocols (SPIRIT& PRISMA-P)
• Systematic reviews (PRISMA& Extensions)
• Diagnostic/prognostic studies (STARD& TRIPOD)
• Case reports (CARE& Extensions)
• Clinical practice guidelines (AGREE& RIGHT)
• Qualitative research (SRQR& COREQ)
• Animal pre-clinical studies (ARRIVE)
• Quality improvement studies (SQUIRE& Extensions)
• Economic evaluations (CHEERS)

Abstracts should contain from 150 to 250 words. Abstracts should not contain acronyms, references, or illustrative materials. 

Abstracts of the original article should be structured so as to contain:

• INTRODUCTION;
• AIM;
• METHODS;
• RESULTS;
• CONCLUSIONS.

Abstracts of narrative reviews and case reports can be prepared without structuring.

Four to five keywords should be provided.

The original article should contain the following sections:

Introduction

The introduction should include:

• a brief review of the literature with emphasis on recent research;
• research justification;
• research objective;
• research hypothesis.

Material and methods

These should ensure the possibility of the research being reproduced by other research groups by providing sufficient details to allow reproduction using the described study methods, and should include:  

• design of the study;
• methods:
  
  • inclusion and exclusion criteria;
  • key and additional research outcomes;
  • methods of the outcome estimation with an indication of the diagnostic tools and equipment used;
  • principles of study group formation.
• characteristics of patients or other objects/subjects of research;
• methods of statistical analysis.

The process by which study groups were formed can be presented graphically (“patient flow chart”). When referring to any equipment used in the study, you should indicate in brackets the manufacturer and country of origin; when listing drugs and chemicals, you should specify their international non-proprietary name, dosage, and route of administration.

If your study has been performed on humans or animals, please specify the ethics committee that has approved your research (please provide its conclusions, indicating document number, date of signing, and the official name of the ethics committee), as well as information about the informed, signed consent of the participants or evidence of compliance with the principles of bioethics.   

Results

The research results should correspond with the research purpose and should offer data to confirm or reject the research hypothesis. Illustrative materials (graphs, tables, or figures) should be used with the relevant references in the text. Please avoid any repetition of information from illustrative materials in the text. It is recommended that you include no more than five illustrative elements. If necessary, tables with data or measuring scales, etc., may be presented as supplementary material to the main manuscript.     

Discussion

The discussion should contain new and important aspects of the study results, an analysis of any possible mechanisms, and an interpretation of the results, as well as comparisons with other studies. Recommendations for clinical practice and the application of results in practice or in future studies are welcomed. The section should describe the strengths and weaknesses of the study, and make appropriate comparison with existing analogues. You should avoid any repetition of information from the ‘Introduction’ section and too detailed a presentation of the data from the ‘Results’ section.

Possible structure of the ‘Discussion’:

• main result – summary of the answer to the research question (one paragraph);
• strengths and limitations of the study;
• comparison of the results obtained with data from other studies, with an analytical assessment of your own results by comparison with other studies;
• application of the results – with regard to research activities, practical work, healthcare organizations.

Conclusion

The conclusion should be brief (a few sentences only) and should summarize the work carried out, the novelty of the data obtained, and the prospects for its future use. 

A review may be systematic, or systematic with a meta-analysis or narrative. The type of review should be indicated in the title of the manuscript.

• Systematic review and meta-analysis

Prior to submitting the manuscript, you should register the systematic review with PROSPERO (https://www.crd.york.ac.uk/prospero/). When registered, the registration number of the review in PROSPERO should be indicated in the manuscript.   

When preparing a manuscript with a systematic review and meta-analysis, you should follow the PRISMA (http://prisma-statement.org/PRISMAStatement/Checklist.aspx) or AMSTAR (https://amstar.ca/Amstar_Checklist.php) systematic review plan. 

• Narrative review

The narrative review should contain an introduction that indicates the review justification and purpose. The main text of the review should be structured, and information should be presented in the titled sections. The review should include a discussion of the obtained results. The conclusion (obligatory section) should summarize the results, comply with the review’s purpose, and specify potential areas for the use of the data obtained in research and medical practice.

The full text of a clinical case report should include:

• introduction (including a brief literature review);
• the clinical case;
• discussion of the results (with a comparison with previous results from the literature);
• conclusions.

• Acknowledgements (this section is optional).
• Authors’ contributions.
• Conflicts of interest.
• Sources of funding.

Authors’ contributions

An example of authors’ contribution information:

• Authors’ contributions: A.M. Ivanov - research design development; B.S. Petrov, G.P. Sidorov - obtaining data for analysis, data analysis; M.M. Ivanova - writing manuscript; O.D. Sidorova - publication review; A.I. Semenov - study idea and purpose development, conceptualization of results. All the authors made a significant contribution to the article, check and approve its final version prior to publication.

Acknowledgement (optional):

The provision of funding or laboratory materials and tools, technical article editing, scientific advice, or general management of the research team do not in themselves justify inclusion in the list of authors.

All team members who do not meet the criteria for authorship but who have assisted in conducting the research and writing the article should be listed, with their consent, in the ‘Acknowledgement’ section.

An example of acknowledgement information:

• Acknowledgement. The authors are grateful to MD A.A. Ivanov for providing scientific advice and for correcting the article, and to V.V. Petrov, the director of Hospital No. 1, for providing administrative support for the study.

Conflicts of interest

Conflicts of interest should be declared for all authors in all types of articles. A conflict of interest implies the existence of any relations and/or personal interests that could potentially affect the results, interpretation of the data, and its unbiased perception. A conflict of interest can occur in the case of financial relations and cooperation with any organization (e.g., fees, educational grants, participation in expert councils, membership, work relations, consultancy work, ownership of a shop in a private property, etc.). In addition, a conflict of interest could relate to non-financial interests (e.g., personal or professional relationships, etc.) with regard to issues discussed in the article and/or materials.

If there are no conflicts of interest, please give the following statement at the end of the article:

An example of Conflict of interest information:

• Conflict of interest. The authors declare no conflicts of interest.

Funding information

Research funding/review or clinical case report should be indicated. We request that you indicate whether the research received financial support, and the source of funding (grant, company support, etc.).

An example of Funding information:

• Financing. The study was performed without external funding.
  or
• Financing. The study was performed with the support of… (official name of the company).
  or
• Financing. The study was supported by the Russian Science Foundation (grant no.).

Editors request that authors comply with the NLM (National Library of Medicine) citation style when formatting references.

In order for the data relating to authors’ publications to be correctly presented in the international abstract and citation databases of research (SCOPUS, Web of Science, Google Scholar, etc.), you should follow certain rules when formatting references in a paper and in the list of references.   

Editors would prefer authors to provide lists of references in English, considering the translation or transliteration of non-English sources in compliance with the presented recommendations.

The website https://www.citethisforme.com can be used to automatically generate a correct bibliographic description of an article in English in the NLM citation style.  

In-text citations

• Each reference should be identified sequentially in the text, figures, or tables in square brackets and using arabic numerals. It is only possible to cite the reference in the figure or the table if it is in sequence with the references cited in the text;
• For multiple citations, place a comma (no space in front) between the numbers; join a closed series with a hyphen;
• Only the authors’ surnames should be quoted in the text. If there are two authors, provide both surnames; if there are more than two authors, quote the first surname followed by “et al.”.

General requirements for sources. It is recommended that you include bibliographic descriptions of scientific sources from the last decade in the list of cited sources (this does not refer to publications on the history of psychiatry). References to your own publications should not exceed 10% of the total number of citations.  

Types of sources. It is acceptable to cite any source; however, references to unpublished work, state documents (government regulations, laws, etc.), or newspaper articles should appear as footnotes or in the text rather than in the list of references.  

Order of presenting sources. The list of references should appear on a new page at the end of your paper. The page should feature the header ‘References’. References are to be listed numerically in order of citation, NOT in alphabetical order.

Presentation and number of authors. Authors’ names and initials should be specified in the list of references without a dot. If there are up to six authors, all authors should be listed. If there are more than six authors, only the first three authors should be listed, followed by “et al.” A comma should be inserted between the name of the last author and “et al.”

Titles and abbreviations. It is unacceptable to abbreviate (or change) the titles of articles or the names of journals. With reference to English language journals, official journal title abbreviations are acceptable. To find an authoritative list of journal title abbreviations, use the CAS Source Index, WorldCat library, or the Web of Science (ISI) catalogue, or MedLine catalogue (NLM Catalogue). If no official abbreviation for the journal title can be found, the name of the journal should be specified in full.

DOI. In all cases, when the source cited has a Digital Object Identifier (DOI), this should be specified at the end of the reference. To verify whether the DOI is valid, visit http://search.crossref.org/ or https://www.citethisforme.com, and enter the title of the source in English in the search box. The latter site, in addition to the DOI, automatically generates a correct bibliographic description of the article in English in the NLM citation style. The vast majority of journal articles since 2000 have been registered with CrossRef and thus have a unique DOI. 

Punctuation:

• when indicating the author’s name, the initials should be placed after the surname;
• initials should not have spaces or points between them;
• authors’ names should be separated by commas;
• a full stop should be inserted after the name of publication;
• when indicating the date of the publication, publisher, or other data, the punctuation should comply with the examples listed below.

Language

References should be presented in Latin script. References to sources in non-Latin script should be presented as per the OFFICIAL TRANSLATION or TRANSLITERATION (depending upon the specific element of the description). 

Translation and transliteration

Non-English information on sources in the list of references should either be transliterated (using the Latin script alphabet) or translated.

• If an article is presented in Latin script, it should be cited in the original language;
• If an article is presented in non-Latin script, an OFFICIAL TRANSLATION or Latin script transliteration should be provided. For books, a Latin script transliteration should be provided. The original language of the article should be indicated after the title, prior to the journal name;
• References may include both transliterated (e.g., authors’ names, names of journals) and translated (e.g., publication title) elements.

Transliteration standard. Use the BSI (British Standard Institute, UK) standard for transliteration: https://antropophob.ru/translit-bsi.

• Names of authors, editors. Surnames and initials of all authors should be indicated in the reference as they appear in the original publication. If the authors’ names are presented in the original publications in Latin script, this variant should be used in the reference (regardless of the transliteration system used in the original source). If the authors’ names are not given in Latin in the official sources (journal websites, databases), they should be transliterated in accordance with the BSI standard.
• Article title. If the article cited has an official translation or a translated title in English (this should be checked on journal websites or in databases), this variant should be given. If no title is presented in Latin script in the official publication, a title transliterated in accordance with the BSI standard should be provided.
• Journal title. Certain non-English, scientific journals have official titles in English in addition to titles in native languages (e.g., the Russian Journal of Psychiatry, in addition to the Russian language title, has both the official name in English, ‘Russian Journal of Psychiatry’ and the transliterated title ‘Rossiiskii psikhiatricheskii zhurnal’). Thus, either the translated or transliterated title of the journal should be provided in the reference. The translated title of the journal may be taken from the official journal’s website (or where it is possible to use data governing the accurate quotation of English language titles from the article cited) or checked in databases. You should not translate journal titles yourself.
• Place of publication. According to the NLM Citation Guide (last edition), you need not indicate the place of publication.
• Name of publisher. The name of the publisher should only be transliterated (except in rare cases where publishers have official English language titles).

Examples of citing in ‘References’

All examples can be found under the link: https://www.ncbi.nlm.nih.gov/books/NBK7256/. Should you require any additional information or assistance, the CP editorial team is at your disposal (editor@consortium-psy.com)

Units should be provided in the International System of Units (SI). If the study was carried out using devices that provide measurements in other units, these need to be converted to the SI system with an indication of the conversion factor or software version in ‘Materials and methods’.

Abbreviations/acronyms should not be used except for those that are generally accepted. The meanings of abbreviations/acronyms in the text of the article must be given in full at their first mention (e.g., neuromuscular disease (NMD)).

Gene names should be specified in italics; protein names should be specified in regular font.

Illustrative materials can include photographs, figures, images, diagrams, graphs, charts, and tables. Illustrative materials should be submitted in the form of high-quality images to enable good picture reproduction quality in both the electronic and printed versions of the journal. Should the illustrative materials have previously been published, the author is obliged to provide permission for their use otherwise their use will be considered plagiarism and the study will not be accepted for publication.

Illustrative material should be submitted as separate files and should be accompanied by links in the relevant sections within the body of the article text. References should appear in parentheses, e.g., (fig. 1), (table 1).

Figures, graphs, diagrams, and charts should be provided in editable formats. Illustrative materials should meet further technical requirements:  

• tables should be presented in their original Word or Excel versions. If other programs were used (e.g., EndNote), the associated files should be provided in PDF format, with a copy function available;
• images, illustrations, graphs, and diagrams should be presented in TIFF or EPS format; JPG files should have a resolution of at least 300 dpi (dots per inch);
• photographs are accepted in TIFF or JPG format, with a resolution of at least 300 dpi. If a photograph is small (for example, 3 × 4 cm), you should choose a resolution of 1200 dpi when scanning. The eyes of patients or healthy subjects in photographs should be masked; if not, the author should submit patients’ written permission for their full likenesses to be presented.

If you cannot provide files in these formats, please contact the editorial staff for assistance.

All figures must be numbered and provided with captions. Fragments/elements of figures should be presented as lower-case letters – “a”, “b”, etc. All abbreviations, symbols in the form of curves, letters, numbers, etc., used in the figure should be explained in an associated caption.

Tables should be ostensive and should display a title and serial number. Graph headers should correspond to their content. The data in the tables should not repeat any data in the figures or text, or vice versa. All abbreviations/acronyms should be explained in a footnote to the associated table. You need to specify the statistical method used for analysis and for the corresponding confidence value (p). All information contained in the table, including its title and notes (if applicable), should be presented in the language of the article. If the table size exceeds one typewritten page, the table should be provided as a separate file in a DOC, DOCX, or RTF format.

Author’s license agreement (public offer) on the publication of an article in a scholarly journal
“Consortium Psychiatricum”

Eco-Vector, represented by its CEO Evgeniy Schepin and acting on the basis of the Charter (hereinafter referred to as the Publisher), on the one hand, offers an indefinite circle of persons (hereinafter referred to as the Author), and on the other hand, hereinafter jointly referred to as the Parties, to execute this agreement (hereinafter referred to as the Agreement) on the publication of scientific article (hereinafter referred to as the Article) in a scholarly journal “Consortium Psychiatricum” (further-the Journal) in accordance with the conditions stated below.

I. General Provisions

1. This Agreement, in accordance with clause 2 of Article 437 of the Civil Code of the Russian Federation, is a public offer (hereinafter referred to as the Offer) requiring full and unconditional acceptance (Acceptance), which, in accordance with Article 438 of the Civil Code of the Russian Federation, means the sending by the Author of his/her materials by way of uploading the same to the online electronic system designed to accept manuscripts for consideration, and subsequently posted in the corresponding section of the Journal’s website on the Internet information and telecommunications network (hereinafter referred to as the Internet).
2. In accordance with the current legislation of the Russian Federation regarding the observance of copyright on electronic information resources, all materials found in a website, including submitted and published in electronic journals, may not be reproduced in whole or in part in any form (electronic or printed) without the prior written permission of the Publisher. Prior permission can be given by publishing an article in the open access with Creative Commons license. The journal requires license users to reference the original source, i.e., the publication, if the Author permits use of the public materials in the context of other documents.

II. Terms used in the Agreement

1. “Author” refers to an individual (or individuals) whose creative work has led to the creation of the manuscript of a scientific Article, or to a representative of these persons.
2. “Manuscript” is the result of intellectual activity in the form of a scientific work containing text, graphic and numerical data, audiovisual information, program code and other elements submitted by the Author for publication in the Journal; it is also the mean “a draft of an Article submitted by the Author to be published in the Journal”.
3. “Offer” is the current agreement (an offer to the author for the publication of an Article in the Journal).
4. “Publication” is the process of placement of an Article in the Journal.
5. “Article” is the manuscript that has been published in the Journal (after successful selection, editing, type-setting, copyediting, proofreading, translation).
6. “Acceptance of the offer” refers to the full and unconditional acceptance of the offer on the terms specified in paragraph 3 of this agreement (the Author accepts offer by submitting a Manuscript to the Publisher via the online electronic submission system on the Journal’s Internet website).
7. “Journal” is a scientific peer-reviewed periodical registered as a mass media entity in the Roskomnadzor register of the Russian Federation and ISSN-center.
8. “Submission” is an electronic appeal of the Author to the Publisher for the publication of an Article in the Journal by uploading the manuscript and accompanying materials to the online electronic submission system on the Journal’s Internet website).
9. “Publisher” refers to Eco-Vector, which is the Publisher of the journal.
10. Article metadata includes the information that are intended for inclusion in International Scientific Databases and search engines, namely the following:
    
    • title of the Article;
    • information about each of the Authors (surname and first name; patronymic; place of work with the postal address indicated, contact information (e-mail));
    • abstract;
    • keywords;
    • thematic rubricator: UDC (Universal Decimal Classification) or other library and bibliographic classification and subject indexes;
    • list of references.
11. “Editorial board” is the creative team that prepares the journal for publication.
12. “Parties” refers to the Author and the Publisher.
13. “Author Guidelines” are the requirements for Articles published in the Journal, posted in the “For authors” section of the Journal’s Internet website.

III. Subject of the Agreement (Offer)

1. Under this agreement, the Author grants the Publisher, free of charge for the entire period of validity in accordance with the legislation of the Russian Federation, an exclusive license to use the Article created by the former for publication in the Journal, as well as the rights to use the article in the following ways:
   
   • Reproduction of the Article or its sections or parts, as well as the metadata of the Article in any languages, in any material form, including on paper and electronic media, as a separate work in Journals and/or databases (local or in the Internet) of the Publisher and/or other persons, at the discretion of the Publisher;
   • Distribution of the Article or its sections or parts, as well as the metadata of the Article in any languages, on any medium as part of the Journal and/or databases of the Publisher or other persons, at the discretion of the Publisher, or as an independent work around the world whether on Open-Access terms or for a fee without remuneration to the Author;
   • Making the Article or any of its sections or parts, as well as the Article’s metadata in any languages, publicly available in such a way that any person can access the Article from any place, including via the Internet, and at any time of their own choosing;
   • Granting permission/s for the use of the Article or its sections or parts, as well as its metadata in any languages, to third parties with notice to the Author made by posting relevant information on the Journal’s website, without paying remuneration to the Author;
   • Processing the Article (i.e., editing, correcting, annotating, tagging, translating to any languages, typesetting) and using the revised (translated) Article in the aforementioned ways.
2. Other rights not directly transferred to the Publisher under this Agreement, including patent rights to any process, method etc., described by the Author in the Article, as well as trademark rights, are reserved for the Author.
3. The territory where the rights to the Article are allowed to be used is the whole world.
4. The validity of this Agreement commences only if the manuscript of the Article is accepted for publication in the Journal and only from the moment of sending a notification of acceptance of the Article for publication to the Author from the official e-mail of the Journal.
5. The rights are granted by the Author to the Publisher free of charge; the publication of the Article in the Journal does not entail any financial deductions to the Author.
6. If the Publisher decides to reject the Submission or refuse to publish the Article in the Journal (i.e., retraction of the published Article), this Agreement becomes invalid. The decision to refuse publication will be sent to the Author at the e-mail address specified in the Submission.

IV. Rights and Duties of the Parties

1. The Author guarantees that:
   
   • s/he holds the copyright the exclusive rights to the materials submitted to the Publisher as part of the manuscript of the Article;
   • the rights granted to the Publisher under this agreement have not been previously transferred and will not be transferred to third parties in the future during the duration of the Agreement;
   • the manuscript contains all references to the cited authors and/or publications (materials) provided for under the current copyright legislation;
   • the Author has obtained all the necessary permissions for all information and other materials s/he holds no copyright to and that are used in the manuscript of the Article;
   • the Article manuscript contains only materials permitted to be published in the open press in accordance with the current legislative acts of the Russian Federation, and its publication and distribution will not lead to the disclosure of secret (confidential) information (including state secrets);
   • the Author has informed co-authors about the terms of this Agreement and has received their consent to execute this Agreement under the terms provided for in the Agreement.
2. The Author carries certain obligations under the terms of the Agreement:
   
   • s/he should prepare and submit the manuscript of the Article in accordance with the Author Guidelines posted on the Journal’s website;
   • the Author should not use an electronic copy of the Article for commercial purposes and in other journal publications without the consent of the Publisher;
3. in the process of preparing a manuscript for publication, the Author is obligated to undertake the following:
   
   • make corrections to the text of the manuscript that have been marked by the peer-reviewers and accepted by the editorial board, and/or as necessary, upon the request of the Publisher and the editorial board, finalize the manuscript of the Article;
   • revising and proofreading the manuscript of the Article in accordance with the editorial recommendations;
   • suggest only the minimum of corrections to the type-setted (layout) Article.
4. The Author has the following rights and duties:
   
   • Use preprint or prior-to publication versions of an unpublished Article in the form and content accepted by the Publisher for publication in the Journal. Such prior-to-publish versions can be placed as electronic files on the personal websites of the Author (co-authors) or on the protected external websites of the employers of the Author; however, the Author cannot use the unpublished version(s) for commercial sale or for systematic external distribution by a third party (i.e., post on social media). The author or co-authors must, in turn, carry out certain duties, namely:
     
     • include the following warning in the prior-to-publish version: “This is prior-to-publish version of the article accepted for publication in (Journal’s name), © Eco-Vector (year)”;
     • provide the corresponding electronic link to the Publisher’s website at https://journals.eco-vector.com/ and/or via the DOI.
   • Copy or transfer a copy of the published Article in whole or in part to colleagues free of charge for their personal or professional use, for the promotion of academic or scientific research, or for informational purposes of the Author’s employer.
   • Use materials from a published Article in a book written by one of the co-authors.
   • Use figures, tables and text excerpts from the Article for his or her (or co-authors’) own training purposes, or to include them in other published works in printed or electronic format by a third party, or to submit them in electronic format on an internal computer network, or on the public website of the Author (co-authors) or his/her employer.
   • Include the Article in educational collections for use in the classroom, either for free distribution to the Author’s (co-authors’) students or in electronic format on a local server for access by students as part of the training course, as well as for internal training programs at the institution of the Author’s employer.
5. The Publisher, for its part, is obliged to:
   
   • publish the Author’s article in the Journal in printed and electronic form in accordance with the terms of this Agreement;
   • if necessary, as so decided by the Journal’s editorial board, provide the Author with the proofreading of the manuscript and make a reasonable editing;
   • provide to the Author the unlimited access to the final electronic version of the published Article (Version of Record) through the online electronic submission system on the Journal’s Internet website;
   • comply with the Author’s rights as provided for by the current legislation, as well as protect them and take all necessary measures to prevent copyright infringement by third parties.
6. The Publisher has a right to:
   
   • conduct an expert evaluation of the manuscript (peer-reviewing and editorial evaluation) and invite the Author to make the necessary changes (revisions) to the manuscript;
   • provide editing, copyediting, type-setting, proofreading, tagging, indexation and translation of the Article’s manuscript without altering the main content;
   • in any subsequent authorized use by the Author (and/or other persons) of the Journal and/or Article (including any separate part or fragment thereof), require that a link to the Journal, Publisher, Author or other copyright holders, the title of the Article, the Journal’s volume/issue, and the year of publication be specified in the Journal;
   • post preliminary and/or advertising information about the upcoming publication of the Article in the media and other information sources;
   • make changes to the offer in accordance with the procedure established by the offer.
7. The editorial board of the Journal, headed by the editor-in-chief, has the exclusive rights to select and/or reject materials sent to the Journal editorial office for publications purposes. The manuscript sent by the Author to the Journal editorial office is not subject to return. The editorial board of the Journal does not enter into correspondence about rejection of submissions.
8. In all cases not stipulated and not provided for in this agreement, the parties are obliged to be guided by the relevant current laws of the Russian Federation.

V. Acceptance of the Offer and Execution of the Agreement. Terms of the Agreement

1. The Author accepts the Offer by submitting the manuscript on the Article to the Publisher through the electronic manuscript submission system on the Journal's Internet website.
2. Acceptance of the offer by the author creates an Agreement in writing (Articles 438 and 1286.1 of the Civil Code of the Russian Federation) on the terms of the offer.
3. This Agreement is valid for the duration of the exclusive rights to the Article.
4. When transferring (alienating) the exclusive right to the Article by the Author to a third party, this Agreement does not terminate.

VI. Procedure for changing and terminating the Agreement

1. The Publisher has the right to unilaterally change the terms of this Agreement, in advance, at least 10 (ten) calendar days before the entry into force of the intended relevant changes, but with notice to the Author through the Journal’s website or by e-mail to the Author’s e-mail address specified in the Author’s Submission. The changes will take effect from the date specified in the relevant notification.
2. If the Author rejects the changes to the terms of this Agreement, s/he has the right to notify the Publisher by sending a written notification through the online manuscripts submission system, making sure that the same is sent to the official e-mail address of the editorial office.
3. This Agreement may be terminated prematurely, either by agreement of the parties at any time, or on other grounds provided for in this Agreement.
4. The Author has the right to unilaterally withdraw from the execution of this Agreement by sending the Publisher a corresponding notification in writing at least 60 (sixty) calendar days in advance before the expected date of publication of the Article in the Journal.
5. Termination of the Agreement for any reason does not release the parties from liability for any violation of the terms of the Agreement that occurred during the validity period.

VII. Responsibility

1. The parties are responsible for non-fulfillment or improper fulfillment of their obligations under the Agreement in accordance with the current relevant legislation of the Russian Federation.
2. All information provided by the Author must be reliable. The Author is expected to provide accurate and complete the information to the Publisher. When using false information received from the Author, the Publisher is not responsible for the negative consequences caused by his actions on the basis of the false information provided.
3. With regard to the content of the Article, the Author is solely responsible for compliance with the requirements of the laws of the Russian Federation pertaining to advertising, copyright and related rights’ protection, protection of trademarks and service marks, and the protection of consumer rights.
4. The Publisher does not bear any responsibility under the agreement:
   
   • for any actions that are a direct or indirect result of Author’s illegal actions;
   • for any loss incurred by the Author, regardless of whether the Publisher could have foreseen the possibility of such losses or not.
5. The Publisher is released from liability for violation of the terms of the Agreement if such violation is caused by force majeure, including actions of state authorities (including the adoption of legal acts), fire, flood, earthquake, other natural disasters, lack of electricity and/or computer network failures, strikes, civil unrest, riots, etc.

VIII. Dispute resolution

1. Disputes and disagreements will be resolved by the parties through negotiations, and in case of failure to reach an Agreement they will strive to seek resolution in accordance with the current legislation of the Russian Federation.
2. If there are unresolved disagreements, the parties agree to resolve the disputes in court at the jurisdiction covered by the Publisher’s location in accordance with the current legislation of the Russian Federation.

IX. Miscellaneous

1. All notifications, messages, requests, etc. (with the exception of documents that must be sent as originals in accordance with the laws of the Russian Federation) are considered received by the Author if they were transmitted (sent) by the Publisher through the Journal’s website (including by publication), fax, e-mail based on the address specified in the Submission, and other communication channels. The parties recognize the legal force of notifications, messages, requests, etc., transmitted (sent) by the above methods.
2. In the event of claims against the Publisher related to the violation of the exclusive copyright and other intellectual property rights of third parties when creating an article or in connection with the execution of this Agreement by the Author, as well as in connection with the use of the Article by the Publisher in accordance with the Agreement, the author undertakes:
   
   • To immediately take measures to resolve disputes with third parties soon after receiving Publisher’s notification, and if necessary, enter into legal proceedings on the Publisher’s side and take all appropriate actions needed to exclude the Publisher from the list of defendants;
   • To reimburse the publisher for the legal costs incurred and expenses and losses caused by the application of measures to secure the claim and execute a court decision, and the money paid to a third party for the violation of exclusive copyright and other intellectual property rights, as well as other losses incurred by the Publisher in connection with the Author’s non-compliance with the guarantees provided by them under this Agreement.

X. Legal address and details of the Publisher

• Eco-Vector
• Address: 191186, St. Petersburg, Aptekarsky Pereulok, 3 letter A, room 1N
• TIN: 7806423692; KPP: 784101001; OGRN: 1099847039907.